| Literature DB >> 34909223 |
Sheryl de Waard1,2, Jacqueline van der Vis1, Pascale A H T Venema1, Inger N Sierevelt1, Gino M M J Kerkhoffs2, Daniël Haverkamp1.
Abstract
Total hip arthroplasty is performed more frequently in younger patients nowadays, making long-term bone stock preservation an important topic. A mechanism for late implant failure is periprosthetic bone loss, caused by stress shielding around the hip stem due to different load distribution. Short stems are designed to keep the physical loading in the proximal part of the femur to reduce stress shielding. The aim of this review is to give more insight into how short and anatomic stems behave and whether they succeed in preservation of proximal bone stock.A systematic literature search was performed to find all published studies on bone mineral density in short and anatomic hip stems. Results on periprosthetic femoral bone mineral density, measured with dual-energy X-ray absorptiometry (DEXA), were compiled and analysed per Gruen zone in percentual change.A total of 29 studies were included. In short stems, Gruen 1 showed bone loss of 5% after one year (n = 855) and 5% after two years (n = 266). Gruen 7 showed bone loss of 10% after one year and -11% after two years. In anatomic stems, Gruen 1 showed bone loss of 8% after one year (n = 731) and 11% after two years (n = 227). Gruen 7 showed bone loss of 14% after one year and 15% after two years.Short stems are capable of preserving proximal bone stock and have slightly less proximal bone loss in the first years, compared to anatomic stems. Cite this article: EFORT Open Rev 2021;6:1040-1051. DOI: 10.1302/2058-5241.6.210030.Entities:
Keywords: DEXA; anatomic stem; bone mineral density; bone stock loss; periprosthetic bone loss; short stem; total hip arthroplasty
Year: 2021 PMID: 34909223 PMCID: PMC8631238 DOI: 10.1302/2058-5241.6.210030
Source DB: PubMed Journal: EFORT Open Rev ISSN: 2058-5241
Fig. 1Gruen zones in short hip stems.
Fig. 2Flowchart with selection of included studies.
Note. BMD, bone mineral density; DEXA, dual-energy X-ray absorptiometry; CT, computerized tomography; FU, follow-up.
Summary of included studies
| Author, year | Patients/hips ( | Age (mean) | M/F | Body mass index (mean) | Follow-up (years) | Design | MINORS |
|---|---|---|---|---|---|---|---|
| Arabmotlag, 2003[ | 15/15 | 48 | 7/8 | – | 2 | CTX | 17/22 |
| Boller, 2019[ | 39/39 | 51 | 13/26 | 28 | 2 | Metha | 12/16 |
| 28/28 | 66 | 16/12 | 27 | 2 | Metha | ||
| Brinkmann, 2015[ | 24/24 | 59 | 12/12 | 27 | 1 | Metha | 16/22 |
| 26/26 | 60 | 16/10 | 27 | Nanos | |||
| Ercan, 2016[ | 62/62 | 57 | 28/34 | 29 | 1 | Minihip | 10/16 |
| Fokter, 2015[ | 19/19 | 60 | 8/11 | 28 | 1 | Unibionix | 16/22 |
| Freitag, 2016[ | 57/57 | 57 | 36/21 | 30 | 1 | Fitmore | 19/22 |
| Gasbarra, 2014[ | 33/33 | 62 | 15/18 | 24 | 1 | Fitmore | 16/22 |
| Hayashi, 2016[ | 21/21 | 68 | 11/56 | 23 | 2 | Trilock | 12/16 |
| Jahnke, 2014[ | 40/40 | 55 | 20/20 | 27 | 1 | Metha | 13/16 |
| Kim, 2011[ | 50/60 | 54 | 22/28 | 26 | 3 | Proxima | 16/22 |
| 50/60 | 52 | 24/26 | 25 | Profile | |||
| Kim, 2016[ | 201/221 | 53 | 118/83 | 30 | 10 | Proxima | 19/22 |
| 400/530 | 53 | 264/136 | 29 | IPS | |||
| Kim, 2016[ | 200/200 | 53 | 138/62 | 30 | 12 | Proxima | 19/22 |
| 200/200 | 53 | 138/62 | 30 | Profile | |||
| Leali, 2004[ | 10/10 | 65 | 4/6 | – | 3 | Revelation | 10/16 |
| Lerch, 2012[ | 25/25 | 59 | 16/9 | 25 | 2 | Metha | 13/16 |
| Meyer, 2019[ | 54/54 | – | – | – | 5 | Fitmore | – |
| Nysted, 2011[ | 43/43 | 55 | 18/28 | – | 5 | Unique | 16/22 |
| 35/35 | 53 | 13/28 | – | ABG-I | |||
| Panisello, 2009[ | 56/56 | 60 | 27/29 | 28 | 5 | ABG-I | 19/22 |
| 54/54 | 59 | 26/28 | 27 | ABG-II | |||
| Parchi, 2017[ | 20/20 | 54 | 11/9 | – | 4 | Metha | 12/16 |
| Rahmy, 2004[ | 24/24 | 62 | 11/18 | 28 | 3 | ABG-I | 18/22 |
| Salemyr, 2015[ | 26/26 | 62 | 11/15 | 27 | 4 | Proxima | 21/22 |
| Shafy, 2016[ | 26/26 | 43 | 20/6 | 27 | 2 | Minihip | 12/16 |
| Sluimer, 2006[ | 40/40 | 53 | 15/25 | – | 2 | Omnifit-HA 1090 | 18/22 |
| Steens, 2015[ | 20/20 | 49 | 12/8 | 26 | 5 | ESKA cut 2000 | 14/16 |
| Synder, 2015[ | 36/36 | 50 | 18/18 | – | 1 | Metha | 12/16 |
| Vd Wal, 2006[ | 25/25 | 62 | 17/8 | – | 2 | ABG-I | 16/22 |
| 26/26 | 60 | 12/14 | – | 2 | ABG-II | ||
| Vd Wal, 2008[ | 24/24 | 60 | 11/13 | – | 2 | ABG-I | 15/22 |
| White, 2008[ | 27/27 | 37 | 14/13 | 25 | 5 | Epoch | 9/16 |
| Wixson, 1997[ | 35/35 | 50 | 16/19 | – | 2 | Custom made | 9/16 |
| Zeh, 2013[ | 25/25 | 60 | 15/10 | 29 | 1 | Nanos | 11/16 |
Note. MINORS, Methodological Index for Non-Randomized Studies.
*Study between two age groups.
**follow-up of Freitag et al, 2016[33].
Classification and course of bone loss per hip stem design from baseline in Gruen 1 and 7 (in %)
| Gruen 1 | Type | Osteotomy | Anchoring | Studies ( |
| 3M | 6M | 1Y | 2Y |
|---|---|---|---|---|---|---|---|---|---|
| ABG-I[ | Anatomic | Trochanter sparing | Metadiaphyseal | 5 | 164 | –11 | –11 | –13 | –12 |
| ABG-II[ | Anatomic | Trochanter sparing | Metadiaphyseal | 2 | 80 | –5 | –7 | –8 | –9 |
| Custom made Biomet[ | Anatomic | Trochanter harming | Diaphyseal | 1 | 31 | –10 | –17 | –8 | |
| CTX[ | Anatomic | Trochanter sparing | Diaphyseal | 1 | 15 | –2 | |||
| Epoch[ | Anatomic | Trochanter harming | Diaphyseal | 1 | 12 | –17 | –19 | ||
| ESKA cut 2000[ | Short | Partial collum | Metaphyseal | 1 | 30 | –3 | –1 | ||
| Fitmore[ | Short | Trochanter sparing | Diaphyseal | 3 | 90 | –3 | 0 | –4 | |
| IPS[ | Anatomic | Trochanter harming | Metadiaphyseal | 1 | 385 | 0 | |||
| Metha[ | Short | Partial collum | Metaphyseal | 6 | 206 | –9 | –9 | –8 | –5 |
| Minihip[ | Short | Partial collum | Metadiaphyseal | 2 | 88 | –11 | –12 | –8 | –3 |
| Nanos[ | Short | Partial collum | Metadiaphyseal | 2 | 51 | –9 | –14 | ||
| Omnifit-HA 1090[ | Anatomic | Trochanter harming | Diaphyseal | 1 | 35 | –11 | –13 | –14 | –13 |
| Profile[ | Anatomic | Trochanter harming | Diaphyseal | 2 | 60 | –27 | |||
| Proxima[ | Short | Trochanter sparing | Metaphyseal | 4 | 333 | –6 | –3 | –1 | –3 |
| Revelation[ | Anatomic | Trochanter harming | Diaphyseal | 1 | 10 | –1 | –2 | –4 | |
| Trilock[ | Short | Trochanter sparing | Diaphyseal | 1 | 65 | –6 | –5 | –3 | |
| Unibionix[ | Short | Trochanter harming | Metadiaphyseal | 1 | 19 | 0 | 5 | 10 | |
| Unique[ | Short | Trochanter sparing | Metadiaphyseal | 1 | 43 | –10 | –9 | –10 | –11 |
| Gruen 7 | Type | Osteotomy | Anchoring | Studies ( |
| 3M | 6M | 1Y | 2Y |
| ABG-I [ | Anatomic | Trochanter sparing | Metadiaphyseal | 5 | 164 | –12 | –22 | –23 | –15 |
| ABG-II[ | Anatomic | Trochanter sparing | Metadiaphyseal | 2 | 80 | –5 | –10 | –16 | –12 |
| Custom made Biomet[ | Anatomic | Trochanter harming | Diaphyseal | 1 | 31 | –17 | –19 | 15 | |
| CTX[ | Anatomic | Trochanter sparing | Diaphyseal | 1 | 15 | –34 | |||
| Epoch[ | Anatomic | Trochanter harming | Diaphyseal | 1 | 12 | –10 | –12 | ||
| ESKA cut 2000[ | Short | Partial collum | Metaphyseal | 1 | 30 | –3 | 1 | ||
| Fitmore[ | Short | Trochanter sparing | Diaphyseal | 3 | 90 | –14 | –6 | –8 | |
| IPS[ | Anatomic | Trochanter harming | Metadiaphyseal | 1 | 385 | –6 | |||
| Metha[ | Short | Partial collum | Metaphyseal | 6 | 206 | –15 | –11 | –13 | –3 |
| Minihip[ | Short | Partial collum | Metadiaphyseal | 2 | 88 | –11 | –12 | –9 | –3 |
| Nanos[ | Short | Partial collum | Metadiaphyseal | 2 | 51 | –9 | –8 | ||
| Omnifit-HA 1090[ | Anatomic | Trochanter harming | Diaphyseal | 1 | 35 | –11 | –13 | –14 | –13 |
| Profile[ | Anatomic | Trochanter harming | Diaphyseal | 2 | 60 | –33 | |||
| Proxima[ | Short | Trochanter sparing | Metaphyseal | 4 | 333 | –11 | –12 | –7 | –13 |
| Revelation[ | Anatomic | Trochanter harming | Diaphyseal | 1 | 10 | –4 | –5 | –5 | |
| Trilock[ | Short | Trochanter sparing | Diaphyseal | 1 | 65 | –9 | –9 | –14 | |
| Unibionix[ | Short | Trochanter harming | Metadiaphyseal | 1 | 19 | –12 | –12 | –15 | |
| Unique[ | Short | Trochanter sparing | Metadiaphyseal | 1 | 43 | –17 | –20 | –21 | –24 |
*Number of patients of two studies (Freitag[33] and Gasbarra[34] as Meyer[32] et al is a follow-up study of Freitag.[33]
Fig. 3Percentual bone loss per type of hip stem in Gruen 1 and 7, with pooled standard error.
Note. BMD, bone mineral density.
Mean percentual change in bone mineral density in short and anatomic stems as a proportion from baseline (< 3 weeks postoperative)
| Short | Time (months) | 3 | 6 | 12 | 24 | 36–60 | 60–120 |
|---|---|---|---|---|---|---|---|
| Nr of hips (G1, G7) | 397 (12) | 456 (12) | 855 (18) | 266 (7) | 335 (4) | 221 (3) | |
| Nr of hips (G2–G6) | 371 (11) | 430 (11) | 582 (16) | 240 (6) | 117 (3) | 63 (2) | |
| Gruen 1 | –7 | –8 | –5 | –5 | 1 | –2 | |
| Gruen 2 | –7 | –5 | –4 | –1 | –9 | –7 | |
| Gruen 3 | –1 | –1 | 0 | 1 | –2 | –4 | |
| Gruen 4 | –4 | –4 | –2 | –1 | –5 | –6 | |
| Gruen 5 | –3 | –2 | –2 | 0 | 0 | –3 | |
| Gruen 6 | –5 | –1 | 1 | 2 | –4 | 0 | |
| Gruen 7 | –12 | –11 | –10 | –11 | –13 | –15 | |
| Anatomic | Time (months) | 3 | 6 | 12 | 24 | 36–60 | 60–120 |
| Nr of hips (G1, G7) | 155 (5) | 245 (6) | 731 (9) | 227 (8) | 504 (4) | 631 (5) | |
| Nr of hips (G2–G6) | 155 (5) | 245 (6) | 257 (7) | 227 (8) | 59 (2) | 157 (3) | |
| Gruen 1 | –9 | –10 | –8 | –11 | –13 | –2 | |
| Gruen 2 | –7 | –4 | –5 | –6 | –7 | 4 | |
| Gruen 3 | –5 | –4 | –2 | –2 | –5 | –1 | |
| Gruen 4 | –4 | –5 | –1 | –1 | –2 | –1 | |
| Gruen 5 | –4 | –1 | –2 | –1 | –1 | 3 | |
| Gruen 6 | –6 | –4 | –4 | –3 | –5 | 3 | |
| Gruen 7 | –10 | –17 | –14 | –15 | –13 | –25 |
Between brackets number of studies.